Integrated Treatment for Opioid Use Disorder and PTSD

Part of paid clinical trials in Charleston, South Carolina.

Sponsor
Medical University of South Carolina
Study ID
NCT06641115
Status
Recruiting
Apply to this trial

Conditions

  • Opioid Use Disorder
  • Posttraumatic Stress Disorder (PTSD)

Eligibility Criteria

Sex
ALL
Age
18 Years - 70 Years
Healthy Volunteers
Not accepted

Interventions

  • HOPE Therapy — BEHAVIORAL
    Helping Opioid Use and PTSD with Exposure (HOPE) therapy is an integrated 10-12 week treatment for opioid use disorder and trauma/posttraumatic stress disorder

Study Details

This study will test a therapy intervention, HOPE, for individuals with opioid use disorder and posttraumatic stress disorder. Interested individuals will need to be taking medications for opioid use disorder (e.g., suboxone, naltrexone, methadone). Interested participants will complete a 10-12 week therapy, and be asked to complete surveys.

Key Dates

Start date
Mar 1, 2025
Status verified
Nov 2025
Primary completion
Aug 31, 2027
Completion
Aug 31, 2027

Study Design

Enrollment
76 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: HOPE Therapy
    Helping Opioid Use and PTSD with Exposure (HOPE) therapy is an integrated 10-12 week treatment for opioid use disorder and trauma/posttraumatic stress disorder
  • No Intervention: Treatment as Usual
    Participants take medications as prescribed and attend standard community substance use treatment services

Primary Outcome Measure

Change in Opioid Use [ Time Frame: through study treatment completion, an average of 12 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Medical University of South CarolinaCharlestonSouth Carolina29403
Tanya C Saraiya, PhD
[email protected]
8438762374

Find similar trials in Charleston, SC

By research site
Medical University of South Carolina· Charleston, SC

Related Studies